You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/nuBfxwcy3Mun/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

2020 Nanoplatforms the only obstacle is a delivery system..Now in Place

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 06:08 UTC on January 26th, 2022.

#molecularbiology
#DerrickRossi
#nanoplatforms

proletarius64

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

Derrick Rossi: 'As soon as I learned about molecular biology that was it, I knew what I wanted to be'
The most significant scientific discovery since gravity has been hiding in plain sight for nearly a decade and its destructive potential to humanity is so enormous that the biggest war machine on the planet immediately deployed its vast resources to possess and control it, financing its research and development through agencies like the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA) and HHS’ BARDA.

https://www.darpa.mil/program/in-vivo-nanoplatforms

LESS